首页 >
法规速递
-
Draft Guidance: Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications-2023/9/21
2023-09-22查看详情 > -
Page: PRIME: priority medicines-2025/1/6
2025-01-07查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第九十批）的通告（2025年第9号）-2025/2/12
2025-02-12查看详情 > -
Document: Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, substantial modification, non-substantial modification-2025/3/18
2025-03-19查看详情 > -
Document: Business process description for PSUSA and other related post-authorisation processes-2025/4/22
2025-04-23查看详情 > -
Document: Agenda of the PRAC meeting 2-5 June 2025-2025/6/2
2025-06-03查看详情 > -
Document: Minutes of the CHMP meeting 24-27 February 2025-2025/7/8
2025-07-09查看详情 > -
Page: Pre-authorisation guidance-2025/8/12
2025-08-13查看详情 > -
国家药监局关于印发医疗器械网络销售质量管理规范现场检查指导原则的通知-2025/9/26
2025-09-28查看详情 > -
Document: Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products-2025/11/4
2025-11-05查看详情 >
